glp-1-based therapy Oral Therapeutics in the Obesity–Metabolic Syndrome–Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies Integrating lifestyle factors like diet

2024;16:e68063

The CaNa2-EDTA was present only to increase solution stability during autoclaving and may be omitted and the buffer and inorganic salt content may changed to suit the operators requirements

GHS-R1a is Gq-coupled and signals through phospholipase C, inositol triphosphate, and intracellular calcium release

Lin XY, Li HB, Juhasz AL, Jiao DD, Zhou L, Xue RY, Tang Y, Luo X, Zhou D, Ma LQ (2025b) Lower cadmium bioavailability and toxicity in Japonica rice than in Indica rice: mechanisms and health implications

CoronationBio has licensed the intellectual property of ODN derivatives for the treatment of obesity and cardio-metabolic diseases and is continuing to work with me and other authors of this manuscript to translate drug candidates into the clinic

Care should be exercised in patients with liver disease